Oncternal Therapeutics Inc - Rasio nilai perusahaan marang dodolan ONCT

Simbol resmi perusahaan oncternal.com (ONCT)

A lack of profitability and rising clinic costs are creating operational challenges for Oncternal Therapeutics (ONCT). The company's price-to-sales ratio demonstrates a support level, where represents the current level of the metric. These risks are mitigated by a diverse range of CAR-T technology research targeting various tumors and the company's status as a scientific developer creating effective methods to combat rare forms of cancer.

Oncternal Corp (ONCT): Nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

Oncternal - rincian analitis lan metrik utama (ONCT)

Pambiji fundamental perusahaan:ONCT, oncternal.com
Produk sing diprodhuksi Oncternal Therapeutics Inc

This indicator reflects the ratio of total enterprise value to revenue minus debt obligations, capturing the historical valuation dynamics of the asset relative to generated cash flows. By analyzing the enterprise value-to-revenue chart, an investor can weigh market optimism against the long-term potential of Oncternal Therapeutics (ONCT) targeted drugs, where the patent protection of molecules creates a fundamental foundation for future demand.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|BLRX (BioLineRx) - Nilai perusahaan marang volume dodolan|CANF: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan aprea.com|Kazia Therapeutics Limited (KZIA) - Rasio nilai perusahaan marang pendapatan|SLXN - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan NCNA|CMRX: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CYCC|Nilai perusahaan marang pendapatan g1therapeutics.com GTHX|Rasio nilai perusahaan marang pendapatan Kronos Bio, Inc. KRON|Koefisien nilai perusahaan marang pendapatan KTRA (Kintara)|Portage Biotech Corp - Multiplikator EV/Sales